No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
609 |
4. Check minimum number of eventsNone |
609 |
5. Include endpoints |
737 |
6. Filter based on genotype QC (FinnGen only) |
737 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna organorum genitalium masculinorum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of male genital organs
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of male genital organs
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5564 | - | 5564 |
| Only index persons | 4801 | - | 4801 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | - | 0.16 |
| Only index persons | 0.18 | - | 0.18 |
| Median age at first event (years) | |||
| Whole population | - | - | 52.91 |
| Only index persons | - | - | 50.02 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 737 | - | 737 |
| Unadjusted period prevalence (%) | 0.32 | - | 0.32 |
| Median age at first event (years) | 58.18 | - | 58.18 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 673
- Matched controls
- 6730
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D29.1
ICD-10 Finland
Benign neoplasm: Prostate
490.3
215.3
204
6
D29.2
ICD-10 Finland
Benign neoplasm: Testis
+∞
110.5
103
*
D29.4
ICD-10 Finland
Benign neoplasm: Scrotum
1183.9
106.3
101
*
D29.3
ICD-10 Finland
Benign neoplasm: Epididymis
982.0
89.9
86
*
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
50.7
48
*
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
28.9
41.4
56
21
KFC00
NOMESCO Finland
Unilateral orchiectomy
21.6
36.7
54
27
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
7.6
29.1
70
101
KFD16
NOMESCO Finland
Partial excision of epididymis
44.7
24.8
30
7
22200
ICD-8 Finland
Benign neoplasm of male genital organs, Testis
+∞
24.1
23
*
22288
ICD-8 Finland
Benign neoplasm of male genital organs, Loco alio definito
+∞
24.1
23
*
KFA00
NOMESCO Finland
Exploration of testis
26.4
17.0
23
9
2223A
ICD-9 Finland
Benign neoplasm of male genital organs, Epididymis
+∞
16.7
16
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.4
15.4
155
758
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.5
14.7
53
126
22210
ICD-8 Finland
Benign neoplasm of male genital organs, Penis
+∞
14.6
14
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2.3
13.8
145
721
2220A
ICD-9 Finland
Benign neoplasm of male genital organs, Testis
+∞
13.6
13
*
KGB00
NOMESCO Finland
Biopsy of penis
29.0
13.0
17
6
22280
ICD-8 Finland
Benign neoplasm of male genital organs, Scroti
+∞
12.5
12
*
D29.9
ICD-10 Finland
Benign neoplasm: Male genital organ, unspecified
+∞
12.5
12
*
N40
ICD-10 Finland
Hyperplasia of prostate
1.8
11.8
285
1941
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
30.6
11.7
15
5
D29.7
ICD-10 Finland
Benign neoplasm: Other male genital organs
+∞
11.5
11
*
XKD00
NOMESCO Finland
Uroflowmetry
1.9
11.1
199
1221
J01DB01
ATC
cefalexin; oral
1.8
10.6
514
4290
UKC02
NOMESCO Finland
Cystoscopy
1.9
10.4
170
1003
ZXC96
NOMESCO Finland
Robot assisted procedure
3.8
10.1
42
116
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
9.9
160
939
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
3.5
9.3
43
130
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
15.8
9.1
14
9
7501
FHL
Testicular exploration (includes removal of biopsy, detorsion or appendix test)
37.2
9.0
11
*
J01MA02
ATC
ciprofloxacin; systemic
1.7
9.0
275
1966
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
18.9
9.0
13
7
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.0
8.9
113
603
NK6AN
NOMESCO Finland
Total body bone isotope imaging
3.7
8.7
37
105
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
8.1
80
382
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.7
295
2214
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
25.3
7.6
10
*
G04CA02
ATC
tamsulosin; oral
1.6
7.5
271
1998
22299
ICD-8 Finland
Benign neoplasm of male genital organs, Unspecified site
+∞
7.3
7
*
Y05
ICPC
Scrotum/testis sympt/compl other
4.9
7.2
22
46
KFW96
NOMESCO Finland
Other operation on scrotum or scrotal organs
30.3
7.2
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
7.1
176
1173
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.2
7.1
75
369
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
3.3
6.8
33
105
N43.4
ICD-10 Finland
Spermatocele
3.3
6.8
33
105
R31
ICD-10 Finland
Unspecified haematuria
1.9
6.6
101
576
M02AA10
ATC
ketoprofen; topical
1.9
6.6
92
509
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
70.5
6.4
7
*
116
Kela drug reimbursment
Prostate cancer
2.1
6.4
75
387
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
6.3
118
720
KFD70
NOMESCO Finland
Excision of lesion of skin of scrotum
+∞
6.3
6
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
6.2
121
748
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
6.2
106
627
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.1
515
4535
C05AA08
ATC
fluocortolone; rectal, topical
1.9
6.0
89
499
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
41
24
18.03
50.03
4.0
2.4
u/l
31.7
63.8
—
6
5
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
20
13
15.79
22.87
3.3
2.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
127
712
1.95
9.72
5.5
4.7
%
31.2
30.8
0.15
83
486
(40768804) Tissue Pathology biopsy report
279
1980
1.66
9.53
2.3
2.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
348
2696
1.55
7.79
8.9
11.5
inr
1.3
1.4
0.38
110
741
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
509
4299
1.59
7.71
6.4
5.1
ug/l
2.7
3.0
0.22
444
3830
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
11
15
7.43
7.57
1.9
4.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
433
3537
1.54
7.50
5.1
4.2
e6/l
142.9
1425.6
—
9
62
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
131
812
1.75
7.16
4.7
3.9
u/l
231.2
244.7
0.86
125
768
(3037467) Urinalysis macro (dipstick) panel - Urine
451
3757
1.52
6.83
5.1
4.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
134
867
1.67
6.22
2.6
2.3
nmol/l
12.2
13.4
0.91
109
772
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
372
3026
1.46
6.02
6.7
7.1
umol/l
11.8
13.2
2.07
359
2886
(3019225) pH of Specimen
95
574
1.75
5.65
5.9
4.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
501
4359
1.47
5.43
8.7
8.3
u/l
78.2
80.6
0.55
467
4108
(3002256) Pathology report gross observation
111
714
1.65
5.24
1.2
1.4
—
—
—
0
0
(3013512) EKG study
232
1767
1.46
5.09
5.1
4.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
527
4655
1.46
5.08
3.9
3.8
mu/l
1.9
2.0
1.29
461
4180
(3017732) Neutrophils [#/volume] in Blood
66
369
1.87
5.07
2.5
3.2
e9/l
4.0
4.2
0.22
43
282
(3009214) Lutropin [Units/volume] in Serum or Plasma
36
161
2.30
4.99
1.7
1.4
u/l
6.3
6.0
0.05
26
129
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
362
2996
1.41
4.99
2.4
2.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
48
246
2.02
4.75
1.8
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
606
5535
1.53
4.68
18.1
17.0
mg/l
28.3
29.8
0.41
503
4509
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
345
2859
1.39
4.59
8.1
8.1
mmol/l
1.2
1.2
0.34
277
2409
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
51
272
1.94
4.53
2.1
1.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
416
3565
1.38
4.46
5.1
5.6
mmol/l
6.6
6.9
2.42
398
3385
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
318
2623
1.37
4.25
4.1
4.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
227
1773
1.41
4.21
2.3
2.2
u/l
293.8
302.7
0.03
213
1661
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
317
2621
1.37
4.15
7.2
7.2
mmol/l
1.2
1.2
0.69
278
2384
(3019069) Monocytes/100 leukocytes in Blood
316
2613
1.37
4.12
6.2
6.5
%
9.0
9.2
0.37
290
2466
(3002030) Lymphocytes/100 leukocytes in Blood
321
2666
1.36
4.05
6.1
6.3
%
25.1
25.8
0.50
291
2504
(3018010) Neutrophils/100 leukocytes in Blood
315
2615
1.36
3.97
5.6
6.1
%
59.3
58.5
0.51
285
2470
(3006504) Eosinophils/100 leukocytes in Blood
313
2599
1.36
3.92
5.9
6.2
%
2.7
2.9
1.10
286
2445
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
231
1831
1.38
3.87
3.1
2.9
u/l
57.5
57.3
0.03
217
1709
(3013707) Erythrocyte sedimentation rate by Westergren method
452
3980
1.35
3.79
4.3
3.9
mm/h
12.8
12.8
0.01
411
3657
(3019550) Sodium [Moles/volume] in Serum or Plasma
620
5763
1.48
3.67
21.5
20.2
mmol/l
139.7
139.6
0.19
601
5618
(3013115) Eosinophils [#/volume] in Blood
337
2850
1.34
3.67
5.6
6.2
e9/l
0.2
0.2
1.29
294
2506
(3022096) Basophils/100 leukocytes in Blood
304
2536
1.34
3.62
6.0
6.2
%
0.6
0.6
0.03
276
2398
(42870588) Differential panel, method unspecified - Blood
242
1951
1.36
3.61
6.1
6.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
256
2084
1.35
3.58
2.8
2.8
ug/l
184.1
203.0
0.55
229
1903
(3023103) Potassium [Moles/volume] in Serum or Plasma
621
5784
1.47
3.54
21.6
20.4
mmol/l
4.0
4.0
0.78
602
5636
(4035726)
76
492
1.61
3.52
1.2
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
52
309
1.73
3.33
1.9
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
236
1916
1.34
3.31
2.2
2.2
nmol/l
76.0
74.6
0.32
198
1685
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
229
1853
1.34
3.28
3.1
3.7
u/l
36.7
36.7
0.00
214
1760
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
56
344
1.68
3.19
2.1
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
324
2765
1.31
3.16
5.4
5.9
e9/l
0.6
0.6
0.55
280
2373
(3013650) Neutrophils [#/volume] in Blood by Automated count
366
3176
1.30
3.15
9.1
9.4
e9/l
4.5
4.4
0.39
328
2769
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
272
2272
1.31
3.09
3.9
3.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
324
2772
1.30
3.08
5.5
5.9
e9/l
0.0
0.0
0.40
280
2394
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
65
420
1.60
3.05
1.4
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
612
5724
1.41
3.04
18.8
16.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
51
311
1.69
3.00
5.1
4.2
mmol/l
24.0
24.9
1.81
44
290
(3019198) Lymphocytes [#/volume] in Blood
329
2828
1.30
3.00
5.5
6.1
e9/l
1.7
2.0
1.60
288
2480
(3007461) Platelets [#/volume] in Blood
648
6136
1.46
2.89
26.8
24.1
e9/l
229.9
230.4
0.07
631
5957
(3035941) MCH [Entitic mass]
648
6140
1.46
2.84
26.7
24.0
pg
30.5
30.6
1.09
636
6028
(3024731) MCV [Entitic volume]
648
6140
1.46
2.84
26.7
24.1
fl
91.2
91.5
0.71
635
6029
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
281
2379
1.29
2.84
2.0
2.1
pmol/l
93.3
91.9
0.15
153
1350
(3026361) Erythrocytes [#/volume] in Blood
648
6141
1.46
2.82
26.8
24.1
e12/l
4.6
4.6
0.17
626
5944
(3044640) Blood type and Crossmatch panel - Blood
225
1851
1.31
2.81
2.8
2.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
648
6142
1.46
2.81
27.0
24.3
g/l
138.0
139.1
0.79
636
6026
(3010813) Leukocytes [#/volume] in Blood
648
6143
1.45
2.80
26.8
24.2
e9/l
7.0
7.0
0.15
628
5947
(3012501) Base excess in Blood by calculation
29
153
1.93
2.74
4.9
5.2
mmol/l
3.0
2.3
0.46
20
100
(3049717) Cytology report of Urine Cyto stain
57
367
1.60
2.74
3.0
2.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
560
5195
1.32
2.70
17.5
15.6
ml/min/173m2
77.8
78.3
0.20
473
4366
(3002582) Erythrocytes [#/volume] in Urine
229
1898
1.30
2.69
4.1
3.5
e6/l
42.0
116.1
1.25
191
1521
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
401
3566
1.27
2.69
3.0
3.0
pmol/l
15.0
15.0
0.10
353
3179
(3000850) Epithelial cells [#/volume] in Urine
167
1329
1.33
2.62
3.2
2.7
e6/l
2.7
3.0
0.32
148
1162
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
97
709
1.42
2.57
8.3
8.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
48
304
1.62
2.48
1.9
1.9
nmol/l
38.0
38.8
0.08
48
292
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
413
3715
1.25
2.40
3.4
3.4
u/l
56.2
60.9
0.52
381
3457
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
49
316
1.59
2.36
1.9
2.0
ug/l
1.2
1.3
0.06
37
278
(40768797) Stomach Pathology biopsy report
97
723
1.39
2.31
1.5
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
281
2436
1.25
2.21
4.3
4.0
ng/l
43.0
57.7
0.80
220
1848
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
229
1940
1.26
2.20
3.3
3.2
ng/l
2101.7
1928.7
0.17
190
1686
(3023368) Bacteria identified in Blood by Culture
232
1971
1.26
2.17
4.4
4.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
138
1098
1.32
2.16
1.7
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
36
221
1.66
2.13
1.6
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
173
1422
1.28
2.12
2.7
2.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
194
1627
1.26
2.02
3.8
3.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
111
869
1.33
1.95
2.9
2.9
%
22.1
24.0
0.80
96
749
(3019309) Folate [Moles/volume] in Red Blood Cells
146
1187
1.29
1.95
1.8
1.8
nmol/l
1155.4
1168.7
0.04
101
914
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
181
1512
1.26
1.94
2.2
2.1
mg/l
3.0
3.0
0.06
153
1294
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
33
2.75
1.93
2.4
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
33
2.75
1.93
2.4
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
33
2.75
1.93
2.4
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
33
2.75
1.93
2.4
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
164
1355
1.27
1.93
3.2
3.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
115
907
1.32
1.92
31.1
29.8
inr
1.4
1.4
0.01
12
120
(3009542) Hematocrit [Volume Fraction] of Blood
530
4960
1.24
1.92
17.7
17.7
%
41.3
40.7
0.88
337
3352
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
78
2.07
1.92
2.8
3.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
158
1.74
1.91
3.8
4.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
34
213
1.63
1.88
1.8
2.8
g/l
0.6
1.6
1.37
25
189
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
72
2.11
1.87
1.8
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
72
2.11
1.87
1.8
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
116
921
1.31
1.85
2.7
2.8
g/l
2.1
2.2
0.80
103
861
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
618
5898
1.30
1.84
12.0
10.9
u/l
28.6
29.6
0.48
588
5690
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
223
1.60
1.82
2.0
2.8
g/l
9.7
11.2
0.99
26
188
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
73
2.08
1.81
1.8
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
240
2084
1.22
1.80
4.7
3.9
e6/l
56.4
133.4
1.12
192
1599
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
54
380
1.45
1.80
1.6
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
29
2.78
1.79
18.9
12.5
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
8
29
2.78
1.79
2.1
2.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
578
5479
1.25
1.77
4.6
4.6
mmol/l
4.3
4.4
0.23
514
5033
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
63
458
1.41
1.77
4.3
3.1
ml/min/173m2
60.9
62.2
0.11
32
188
(3019977) pH of Arterial blood
10
41
2.46
1.76
4.7
4.4
ph
7.4
7.4
—
5
14
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
15
74
2.05
1.76
1.7
1.4
pmol/l
45.0
61.2
—
7
23
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
74
2.05
1.76
1.8
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
74
2.05
1.76
1.8
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
60
434
1.42
1.73
3.4
2.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
200
1716
1.23
1.67
3.9
3.4
e6/l
0.6
0.5
0.08
161
1342
(3026782) Osmolality of Urine
152
1266
1.25
1.67
3.2
2.9
mosm/kgh2o
597.5
590.8
0.15
133
1076
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
31
2.60
1.66
2.7
3.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
150
1.69
1.65
1.4
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
101
801
1.30
1.64
2.5
2.5
%
1.7
1.8
0.57
90
726
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
246
1.53
1.63
2.0
2.7
g/l
6.8
7.1
0.45
25
181
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
246
1.53
1.63
2.0
2.7
g/l
3.5
3.8
0.89
24
172
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
246
1.53
1.63
2.0
2.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
48
338
1.45
1.61
1.3
1.8
g/l
1.7
1.5
0.72
39
300
(3020630) Protein [Mass/volume] in Serum or Plasma
72
545
1.36
1.61
3.2
2.8
g/l
65.9
65.9
0.01
60
500
(3008757) Leukocyte morphology finding [Identifier] in Blood
16
84
1.92
1.60
7.2
5.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
19
106
1.81
1.60
5.7
4.7
%
2.8
1.1
0.50
14
94
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
289
1.48
1.59
2.6
2.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
20
3.02
1.58
3.0
2.7
u/l
195.2
202.6
—
6
20
(3026389) Candida sp identified in Specimen by Organism specific culture
11
50
2.22
1.57
1.5
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
79
609
1.33
1.57
2.3
2.7
e9/l
68.9
68.2
0.07
62
483
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
34
224
1.54
1.57
2.8
3.1
—
1.2
—
0
21
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
78
601
1.33
1.56
1.6
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
121
990
1.27
1.55
2.7
2.8
umol/l
12.2
13.0
0.57
110
928
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
557
5285
1.22
1.54
4.2
4.1
mmol/l
1.3
1.3
0.16
490
4795
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
21
123
1.73
1.52
1.4
1.2
—
36.0
—
0
5
(3024561) Albumin [Mass/volume] in Serum or Plasma
287
2570
1.19
1.52
5.3
5.7
g/l
34.7
34.9
0.20
259
2394
(46235355) HIV 1 and 2 tests - Meaningful Use set
95
756
1.29
1.51
2.0
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
278
2488
1.19
1.47
3.6
3.1
ug/l
0.7
0.8
1.65
201
1655
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
125
1.70
1.45
1.8
1.5
—
—
—
0
0
(4146454)
15
81
1.87
1.41
2.7
2.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
29
2.43
1.39
2.9
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
29
2.43
1.39
2.9
2.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
50
366
1.39
1.39
4.9
3.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
190
1651
1.20
1.38
5.5
4.5
ph
7.4
7.4
0.68
50
318
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
584
5587
1.22
1.38
5.0
5.1
mmol/l
2.6
2.6
0.28
520
5091
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
563
5368
1.21
1.38
5.2
4.8
mmol/l
6.0
6.1
1.54
492
4835
(3013139) Helicobacter pylori Ag [Presence] in Stool
38
265
1.46
1.37
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
569
5435
1.21
1.34
4.8
4.6
mmol/l
1.3
1.3
0.87
508
4951
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
233
1.48
1.34
1.4
2.7
g/l
2.8
3.1
1.67
24
177
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
29
192
1.53
1.34
1.3
2.6
g/l
37.9
37.0
0.29
22
162
(3022145) Colonoscopy Study observation
77
609
1.30
1.30
1.4
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
60
458
1.34
1.30
4.0
4.7
%
0.1
0.2
0.72
17
160
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
85
1049
0.79
1.30
4.2
3.4
mmol/l
2.5
2.4
0.31
76
924
(3017354) Segmented neutrophils/100 leukocytes in Blood
13
69
1.90
1.29
6.2
4.7
%
66.3
55.7
—
6
57
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
68
530
1.31
1.28
3.0
2.7
u/l
34.5
41.9
0.39
61
459
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
65
504
1.32
1.27
4.8
3.7
kpa
5.0
5.2
0.89
59
467
(3014271) Vancomycin [Susceptibility]
9
44
2.06
1.27
2.9
2.6
—
—
—
0
0
(3009343) pH of Capillary blood
64
496
1.32
1.26
4.9
3.8
ph
7.4
7.4
—
6
57
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
70
1.87
1.24
1.9
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
32
221
1.47
1.23
1.9
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
166
1441
1.20
1.22
1.5
1.6
nmol/l
18.5
19.0
0.18
137
1230
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
71
1.85
1.20
1.2
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
37
265
1.42
1.19
2.4
2.5
ug/l
212.6
631.2
1.36
32
257
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
38
2.12
1.18
1.4
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
38
2.12
1.18
1.4
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
61
475
1.31
1.17
4.9
3.8
mmol/l
0.7
1.8
1.42
46
349
(3017143) Hepatitis C virus Ab [Presence] in Serum
76
610
1.27
1.17
1.8
1.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
20
2.51
1.15
3.6
3.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
20
2.51
1.15
3.6
3.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
114
0.43
1.13
1.2
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
30
2.35
1.12
2.9
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
73
1.79
1.11
1.3
2.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
51
391
1.33
1.10
4.9
5.2
ng/l
109.9
113.7
0.07
45
345
(40758558) Short blood count panel - Blood
152
1322
1.19
1.10
6.7
6.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
41
1.96
1.09
4.1
3.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
122
1041
1.21
1.09
4.1
3.6
mmol/l
0.8
0.8
0.98
113
982
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
33
2.13
1.05
1.4
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
56
439
1.30
1.04
3.8
4.3
%
1.4
0.5
0.81
14
132
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
98
1.65
1.04
1.6
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
46
1.97
1.04
1.3
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
22
2.28
1.03
1.4
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
114
1.59
1.03
3.4
3.4
%
62.9
56.7
1.13
18
114
(3017181) Myelocytes/100 leukocytes in Blood
61
485
1.28
1.03
3.9
4.6
%
1.0
0.9
0.14
17
174
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
371
3467
1.14
1.02
4.7
4.4
%
19.7
21.3
1.34
193
1700
(3026493) Urate [Moles/volume] in Serum or Plasma
190
1694
1.16
1.02
3.2
3.0
umol/l
2658.2
6297.1
0.77
168
1473
(3025159) Blasts/100 leukocytes in Blood
54
423
1.30
1.02
4.0
4.8
%
0.1
0.1
0.22
15
139
(3024928) Oxygen saturation in Venous blood
22
147
1.51
1.01
2.6
3.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
50
388
1.31
1.01
1.5
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
139
1212
1.18
0.98
3.9
3.9
ng/l
218.3
422.9
0.86
119
1022
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
120
1033
1.19
0.98
3.5
3.2
e6/l
1.3
0.6
0.75
77
637
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
33
241
1.39
0.98
1.8
1.8
u/l
35.9
38.9
0.32
28
215
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
74
607
1.24
0.97
3.1
2.5
g/l
0.2
0.2
0.01
68
554
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
27
191
1.43
0.96
1.2
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
24
166
1.46
0.95
3.4
3.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
109
1.57
0.94
3.2
3.1
e9/l
5.1
4.4
0.40
17
109
(3021901) Oxygen saturation in Capillary blood
8
143
0.55
0.94
3.3
3.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
118
1.54
0.91
1.1
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
35
263
1.35
0.89
1.2
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
82
688
1.22
0.89
2.9
3.2
umol/l
9.3
11.1
0.23
71
622
(4094501)
9
156
0.57
0.89
1.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
146
1291
1.16
0.88
1.7
1.7
pmol/l
112820946.8
19739701.0
0.60
117
1074
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
333
0.71
0.87
1.2
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
80
1.64
0.85
3.4
2.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
121
1.50
0.83
2.0
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
30
223
1.36
0.83
1.1
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
46
1.75
0.82
1.4
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
173
1911
0.88
0.80
3.0
2.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
74
622
1.21
0.80
3.1
4.2
mmol/l
2.4
1.8
0.97
56
496
(3021601) Nitrite [Presence] in Urine by Test strip
277
2574
1.12
0.79
5.1
4.6
estimate
0.0
0.0
0.00
58
503
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
33
1.82
0.79
1.3
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
33
1.82
0.79
1.3
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
74
1.63
0.78
1.3
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
44
351
1.27
0.76
1.9
1.7
g/l
1.1
1.6
0.82
37
328
(3000093) Morphology [Interpretation] in Blood Narrative
10
59
1.70
0.76
1.0
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
280
2610
1.12
0.75
3.9
3.5
estimate
0.0
0.0
0.00
55
469
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
124
1.46
0.75
1.5
1.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
24
2.09
0.74
1.4
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
537
5193
1.13
0.73
6.9
6.3
mmol/mol
40.6
40.9
0.30
469
4785
(3037756) Immunofixation for Serum or Plasma
20
142
1.42
0.73
2.0
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
25
2.01
0.72
3.0
1.2
nmol/l
0.2
0.2
—
5
16
(3015183) Erythrocyte sedimentation rate
5
25
2.01
0.72
1.8
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
39
1.80
0.72
1.7
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
57
1.59
0.71
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
57
1.59
0.71
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
265
1.30
0.71
2.1
2.5
u/ml
0.3
0.3
0.29
15
144
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
121
1074
1.15
0.71
3.2
3.0
e6/l
1.1
0.9
0.20
75
674
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
101
1.50
0.70
1.1
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
169
1.37
0.70
1.8
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
16
110
1.46
0.69
2.6
2.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
63
531
1.20
0.68
3.8
3.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
27
1.86
0.68
1.0
4.2
—
55758.1
—
0
8
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
1.3
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
88
765
1.17
0.68
1.8
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
11
166
0.66
0.65
4.7
2.9
kpa
7.1
7.9
1.31
11
151
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
164
1.35
0.63
1.8
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
102
904
1.15
0.62
7.9
7.1
mmol/l
1.1
1.0
0.85
94
849
(3037522) Nuclear Ab [Titer] in Serum
72
621
1.18
0.62
1.3
1.3
titre
248.0
372.0
—
10
113
(3000330) Specific gravity of Urine by Test strip
35
280
1.26
0.62
3.2
3.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
18
130
1.39
0.61
3.7
2.0
nmol/l
0.9
0.8
0.22
13
113
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
50
1.61
0.61
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
19
139
1.38
0.61
3.4
3.8
mg/l
37.8
29.8
0.18
11
93
(3018572) Chloride [Moles/volume] in Blood
11
163
0.67
0.60
3.7
9.7
mmol/l
104.4
105.5
0.44
11
145
(3039000) Anion gap in Blood
11
163
0.67
0.60
3.7
9.7
mmol/l
10.5
11.8
0.80
11
145
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
31
388
0.79
0.60
12.1
13.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
122
1.40
0.60
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
1394.4
—
0
20
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
21
0.00
0.60
0.0
7.9
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
71
614
1.17
0.60
6.6
8.8
mmol/l
1.5
1.4
0.20
66
591
(3035350) Ketones [Presence] in Urine by Test strip
276
2600
1.10
0.59
4.0
3.4
estimate
0.0
0.0
0.00
57
488
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
72
1.54
0.59
3.6
2.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
36
1.67
0.56
1.0
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
172
0.69
0.56
1.1
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
153
1402
1.12
0.56
3.9
3.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
68
590
1.17
0.56
8.1
10.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
90
0.55
0.56
1.2
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.55
2.3
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.55
2.3
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
65
1.55
0.55
2.3
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
123
0.65
0.55
1.0
1.1
—
4.1
—
0
10
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
63
1.43
0.52
1.1
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
98
0.61
0.52
1.0
1.3
—
—
—
0
0
(4010399)
48
408
1.19
0.51
1.5
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
7
45
1.56
0.49
2.1
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54
466
1.17
0.49
1.8
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
46
1.53
0.48
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
76
1.45
0.48
2.2
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
29
236
1.24
0.47
4.1
3.8
g/l
0.3
0.3
0.27
22
115
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
86
771
1.13
0.47
1.4
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
120
1.34
0.46
1.3
1.1
—
—
—
0
0
(3000492) Spirometry study
48
556
0.85
0.46
1.5
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
55
478
1.16
0.46
1.7
2.2
nmol/l
376.3
365.0
0.17
49
435
(3009445) Proteinase 3 Ab [Units/volume] in Serum
33
274
1.21
0.45
1.7
1.3
—
10.7
—
0
10
(21494755) Public health laboratory ask at order entry panel
38
448
0.84
0.45
1.2
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
75
669
1.13
0.45
7.5
8.7
mmol/l
10.9
11.0
0.05
69
639
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
35
293
1.20
0.45
2.3
3.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
134
1449
0.91
0.44
1.7
1.7
mmol/l
1.4
1.4
0.07
115
1186
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
19
148
1.29
0.44
2.5
1.9
mg/l
14.2
12.4
0.39
19
136
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
128
0.70
0.43
1.7
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
35
413
0.84
0.42
1.7
1.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
13
96
1.36
0.41
1.2
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
15
0.00
0.41
0.0
2.3
—
197.6
—
0
15
(3022689) Creatine [Moles/volume] in Urine
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
51
446
1.15
0.41
3.1
2.5
g/l
10.5
11.4
0.81
44
407
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
21
168
1.26
0.40
3.4
4.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
35
1.43
0.39
5.2
3.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
19
0.00
0.39
0.0
7.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
19
151
1.27
0.39
1.2
1.4
g/l
1.1
1.2
0.87
19
145
(40760892) CBC W Ordered Manual Differential panel - Blood
124
1151
1.09
0.38
4.6
4.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
156
1463
1.08
0.38
4.4
3.7
estimate
0.0
0.0
0.69
56
459
(3028707) Methadone [Presence] in Urine by Screen method
9
70
1.29
0.36
4.1
3.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
44
500
0.87
0.35
3.8
5.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
73
1.37
0.34
2.3
2.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
200
1.21
0.34
1.6
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
45
1.34
0.34
1.2
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
166
0.78
0.33
1.5
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
182
1.22
0.33
5.6
3.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
48
539
0.88
0.33
1.4
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
53
590
0.89
0.32
2.6
3.0
ng/l
307.7
228.7
0.39
47
534
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
128
1.26
0.32
1.1
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
101
1.29
0.32
2.5
2.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
186
0.80
0.31
1.9
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
343
1.14
0.31
2.5
2.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
32
277
1.16
0.31
1.0
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
97
0.72
0.31
1.1
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
53
1.32
0.31
1.1
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
54
1.30
0.30
1.4
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
76
699
1.10
0.29
1.2
1.2
iu/ml
53.8
38.4
0.20
22
197
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
18
148
1.22
0.29
1.2
1.3
g/l
0.2
0.2
0.67
18
141
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
129
0.77
0.28
1.0
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
76
1.32
0.28
1.5
1.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
120
0.75
0.27
12.6
3.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
26
224
1.17
0.27
2.0
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
66
1.21
0.26
2.5
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
178
1.19
0.26
1.2
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
67
1.20
0.26
1.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
72
0.69
0.26
4.0
3.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
72
0.69
0.26
1.0
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
17
203
0.83
0.26
3.2
2.4
ug/min
101.2
117.3
—
9
118
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
149
0.80
0.26
1.4
1.6
ug/g
188.6
263.0
—
7
94
(4306422)
9
74
1.22
0.25
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
137
0.80
0.24
1.2
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
249
2410
1.05
0.24
10.7
10.4
e9/l
0.0
0.0
0.26
206
1971
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
169
0.83
0.24
1.1
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
106
1.23
0.23
1.2
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
16
189
0.84
0.22
3.1
3.4
umol/l
37.4
35.3
—
10
155
(3012441) Differential panel - Pleural fluid
7
94
0.74
0.22
1.0
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
40
1.25
0.22
3.6
1.2
nmol/l
182.8
147.7
—
5
40
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
69
643
1.08
0.22
1.3
1.2
u/ml
2.6
12.9
2.49
23
241
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
119
1132
1.06
0.21
1.6
1.6
mg/l
1.3
1.5
0.33
92
884
(3034988) Calcium [Moles/volume] in Capillary blood
0
11
0.00
0.21
0.0
1.2
—
1.2
—
0
11
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
3.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.2
—
92.1
—
0
10
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
43
1.16
0.21
5.0
3.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
13
0.00
0.21
0.0
6.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
52
480
1.09
0.20
5.3
3.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
187
0.85
0.20
1.2
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
6
48
1.25
0.20
1.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
14
0.00
0.20
0.0
9.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4062490)
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
12
144
0.83
0.20
1.8
2.4
g/l
121.7
130.4
—
6
111
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
52
1.16
0.19
1.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
53
1.13
0.18
3.0
1.5
%
10.1
11.5
—
6
53
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
58
1.21
0.18
1.6
1.3
nmol/l
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
59
1.19
0.18
1.3
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
36
329
1.10
0.18
2.4
3.8
mmol/l
25.1
25.0
0.07
36
316
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
61
1.15
0.17
1.1
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
157
1.15
0.17
4.1
2.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
72
680
1.07
0.17
4.3
3.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
85
894
0.94
0.17
1.7
1.4
g/l
2.5
2.8
1.38
56
577
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
8
69
1.16
0.16
1.1
1.3
—
9.1
—
0
23
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
209
2035
1.04
0.16
4.2
3.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
78
820
0.95
0.16
7.7
9.2
mmol/l
1.3
1.0
0.29
65
629
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
130
1.16
0.15
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
130
1.16
0.15
1.2
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
76
0.79
0.15
1.3
2.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
450
4443
1.03
0.15
21.2
20.4
%
13.8
13.8
0.00
441
4341
(3003694) ABO and Rh group [Type] in Blood
152
1473
1.04
0.15
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
131
1.15
0.14
1.2
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
112
1.16
0.14
1.4
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
193
1979
0.97
0.14
4.8
4.2
mg/mmol
12.6
11.3
0.09
129
1377
(3005322) IgE [Units/volume] in Serum or Plasma
27
247
1.10
0.13
1.1
1.3
u/ml
293.8
240.1
0.11
22
220
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
128
0.86
0.13
1.5
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
113
1.15
0.13
1.2
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
94
1.17
0.13
3.7
3.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
107
0.84
0.13
1.9
2.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
79
824
0.95
0.12
7.5
9.1
kpa
11.6
11.8
0.20
74
792
(3000494) Fungus identified in Specimen by Culture
73
698
1.05
0.12
1.5
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
398
4030
0.97
0.12
3.9
4.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
79
823
0.96
0.12
7.5
9.1
kpa
5.0
5.1
0.46
72
789
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
62
591
1.05
0.12
1.7
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
65
622
1.05
0.11
2.0
2.5
ug/l
7.4
8.7
0.35
51
557
(3011397) Hemoglobin [Presence] in Urine by Test strip
124
1205
1.03
0.11
3.7
3.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
25
270
0.92
0.10
1.5
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
75
778
0.96
0.10
1.7
2.0
%
1.6
1.6
0.19
62
665
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
61
636
0.96
0.10
4.2
4.4
ug/l
4.5
35.5
1.58
53
536
(3012516) Albumin [Mass/volume] in Urine
183
1866
0.97
0.09
3.8
3.5
mg/l
63.0
260.0
1.97
124
1310
(3051651) Icteric interference index of Serum or Plasma
5
46
1.09
0.09
12.8
4.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
193
1966
0.98
0.09
3.9
3.4
mmol/l
8.1
8.5
0.66
153
1644
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
19
174
1.09
0.09
1.6
2.3
g/l
3.5
3.8
0.29
19
163
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
184
1.09
0.09
1.5
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
17
155
1.10
0.09
1.1
1.2
—
1.5
—
0
13
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
80
775
1.04
0.08
1.5
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
136
1.11
0.08
1.7
1.9
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
58
1.03
0.08
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
58
1.03
0.08
1.5
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
61
0.82
0.08
1.0
1.2
nmol/l
2.0
1.5
—
5
55
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
60
0.83
0.08
1.4
1.3
—
—
—
0
0
(3020891) Body temperature
27
287
0.94
0.08
6.0
4.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
64
1.09
0.08
1.6
2.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
67
1.05
0.08
1.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
18
166
1.09
0.08
4.2
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
74
0.81
0.07
1.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
184
0.92
0.07
1.0
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
184
1811
1.02
0.07
3.9
3.6
mmol/l
2.3
2.3
0.62
152
1589
(3045142) Bone marrow Pathology biopsy report
7
80
0.87
0.07
1.4
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
83
0.84
0.07
1.9
3.1
—
—
—
0
0
(44790049)
7
84
0.83
0.07
1.3
1.8
—
—
—
0
0
(44806118)
7
84
0.83
0.07
1.3
1.8
—
—
—
0
0
(44790048)
7
84
0.83
0.07
1.3
1.8
—
—
—
0
0
(44790047)
7
84
0.83
0.07
1.3
1.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
85
1.06
0.07
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
86
1.05
0.07
1.3
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
111
0.90
0.06
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
50
517
0.96
0.06
2.7
2.7
ug/g
154.5
164.7
0.10
39
432
(3000764) Benzodiazepines [Presence] in Urine
18
168
1.07
0.06
4.1
2.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
98
960
1.02
0.06
1.9
2.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
117
1191
0.98
0.05
4.7
3.8
kg/l
1.0
1.0
0.05
19
167
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
91
929
0.98
0.05
1.2
1.2
u/ml
1.7
1.2
0.20
23
255
(3036489) Thrombin time
22
208
1.06
0.05
1.4
1.8
s
20.9
22.5
0.73
16
191
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
150
0.93
0.04
1.2
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
101
1.09
0.04
1.2
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
18
170
1.06
0.04
4.1
2.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
18
170
1.06
0.04
4.1
2.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
199
0.95
0.03
1.3
1.1
iu/ml
27.6
141.6
—
9
67
(3015235) Bicarbonate [Moles/volume] in Capillary blood
19
199
0.95
0.03
3.6
3.2
mmol/l
25.1
24.7
0.18
19
172
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
102
1.08
0.03
1.2
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
31
319
0.97
0.02
1.5
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
143
1.05
0.01
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
143
1.05
0.01
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
147
0.95
0.01
1.1
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
124
1.05
0.00
1.2
1.0
—
—
—
0
0
(4034850)
19
184
1.03
0.00
16.2
12.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
30
306
0.98
0.00
2.9
4.4
%
53.1
50.0
0.29
30
301
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
95
1.05
0.00
1.2
1.1
—
3.7
—
0
7
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
104
0.96
0.00
3.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
116
1.04
0.00
1.2
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
133
0.98
0.00
3.2
2.5
—
—
—
0
0
(1002224) Polysomnography panel
21
213
0.99
0.00
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
98
1.02
0.00
1.5
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
101
0.99
0.00
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
111
0.99
0.00
1.4
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
12
121
0.99
0.00
1.2
1.5
g/l
25.9
31.1
0.68
12
107
(3050794) Legionella sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
17.0
—
0
7
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
92.7
—
0
9
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
2.0
—
88.7
—
0
6
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.0
—
16.6
—
0
6
(3023199) Leukocytes [#/volume] in Pleural fluid
11
110
1.00
0.00
1.2
1.5
e6/l
1550.2
1833.0
0.13
11
81
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
1.4
—
0
5
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
2.4
—
0
8
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
70
1.00
0.00
1.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
75
0.93
0.00
1.0
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
67
0.89
0.00
11.3
4.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
51
0.98
0.00
1.4
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
60
1.00
0.00
1.5
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
60
1.00
0.00
3.0
2.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MALE_GEN and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MALE_GEN | 1.301 [1.15, 1.47] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 965 out of 3809 males with CD2_BENIGN_MALE_GEN died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MALE_GEN.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.238% |
| 5 | No data | 1.447% |
| 10 | No data | 3.479% |
| 15 | No data | 6.681% |
| 20 | No data | 11.102% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MALE_GEN – Benign neoplasm of male genital organs
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data